Fresh Purchase: Strategy acquired 520 BTC for $34.9 million at a $67,068 average price, funded by $335.5 million in new MSTR stock sales. Balance Sheet Moves: The firm lifted its cash reserves to $1.4 billion while expanding its ATM programs for MSTR, STRC, and STRK to support ongoing liquidity and dividend obligations.
Strategy added 520 BTC as Bitcoin trades near $65K. Is Saylor calling the bottom, or is BTC still facing rejection risk?
Remitly Global is now profitable, with strong revenue growth and expanding customer base, especially among high-value senders and business clients. RELY raised full-year guidance after Q1 2026, projecting $1.96–$1.975 billion revenue and $370–$385 million adjusted EBITDA, reflecting accelerating growth initiatives. Strategic expansion into new customer segments and geographies, plus integrations like WhatsApp and ChatGPT, support a bullish long-term outlook.
Chevron Corp (NYSE:CVX) is up 0.9% in premarket trading after announcing a 20-year agreement to supply natural gas-fired power to a Microsoft (MSFT) data center in West Texas.
CCJ and LEU stand to gain from nuclear growth, but a stronger earnings outlook, contracts and stock performance give CCJ an edge now.
The silver market continues to be a volatile place to trade, as we are still following the latest headlines coming out of the Middle East still. With this, I find it hard to get a big position going in this asset at the moment.
The Energy Select Sector SPDR Fund (NYSEARCA:XLE) has had a volatile two months.
Argentina Lithium & Energy Corp (TSX-V:LIT, OTCQX:LILIF) said Miles Rideout has retired as vice president exploration after five years overseeing the technical programs that advanced the company's lithium assets in Argentina, including the first mineral resource estimate for the Rincon West project. "On behalf of all of us at Argentina Lithium, I would like to thank Miles for his dedication over the last five years,” said CEO Nikolaos Cacos.
Spot gold and silver prices are higher in early U.S. trading Monday, as oil prices fell on progress in U.S.-Iran negotiations and traders balanced lower energy-risk premiums against the Federal Reserve's hawkish June signal.
MT teams up with AWS to bring AI and cloud tools to steelmaking and supply lower-carbon steel under a multi-year deal.
AWR, ED, KO and NYT stand out as low-beta defensive picks as the Fed holds rates steady and signals possible policy shifts amid inflation.
Uniswap price has held above the $3 level after a sharp three-day rally driven by Standard Chartered's bullish coverage and a wave of short liquidations across derivatives markets. According to data from crypto.news, Uniswap (UNI) price traded around $3.
ZS gains an edge over CRWD, with expanding platform adoption and a lower valuation despite strong cybersecurity demand.
SCHW plans to launch S&P 500-linked prediction market contracts with Cboe. This will likely broaden retail trading options and strengthen the platform's appeal.
Summit Therapeutics is a highly volatile, single-asset company with a binary outcome. SMMT exhibits unusually concentrated ownership and heightened short interest, creating conditions for a short squeeze to take place. Recent pullbacks, driven by mixed market receptions to events do not fundamentally alter the investment narratives, present investors with an attractive entry point ahead of key catalysts.
The euro started the week on a softer footing against the dollar, surrendering part of Friday's rebound as investors continued to digest last week's shift in Federal Reserve messaging. Although the EUR/USD managed to stabilise towards the end of the previous week, the overall backdrop remains supportive for the dollar after policymakers at the Fed signalled a more hawkish policy outlook than markets had anticipated, with markets now pricing some 40-45 basis points of hikes by the end of the year.
The largest Ethereum treasury firm slowed its buying pace but remains on track to reach its goal of owning 5% of ETH supply.
Strive's aggressive Bitcoin acquisition strategy heightens its exposure to market volatility, posing significant risks to its financial stability. Strive acquires 759 Bitcoin for $50M, growing its treasury to 19,000 BTC.
Blockmate Ventures Inc (TSX-V:MATE, OTCQB:MATEF, FRA:8MH) announced that it plans to complete a non-brokered private placement to raise gross proceeds of up to $750,000, with the possibility of increasing the total amount to as much as $1 million through oversubscriptions. The offering will consist of up to 15 million units priced at $0.05 each.
Strategy's aggressive Bitcoin accumulation could amplify financial risk, relying heavily on BTC's market performance to justify equity dilution. Strategy adds $35M in Bitcoin, $300M in cash reserves last week.
Warsh's Fed debut, SpaceX's AI deal and Iran headlines fueled a risk-on rally. These 5 leveraged ETFs soared as much as 94% last week.
Apple (NASDAQ: AAPL) shares have been hit with a notable Wall Street downgrade after KGI Securities lowered its rating on the technology giant from ‘Outperform' to ‘Neutral', citing limited upside potential following the stock's strong recent rally.
Revenue surged 88% to $113.6 million while AI-focused CED revenue jumped 158% and reached two-thirds of sales. Management raised full-year growth guidance to at least 80%, signaling stronger visibility and accelerating AI infrastructure demand. Gross margin expanded to 64.5%, operating margin reached 28%, and operating cash flow more than doubled year-over-year.
Taiko urged users to withdraw from all bridges after a chain state verification compromise enabled unauthorized bridge withdrawals. Attackers used forged withdrawal proofs or messages that were accepted on Ethereum without matching legitimate activity on Taiko, draining up to $1.7 million.
Traders remain bullish even as large holders increase downside bets.
UPS is announcing a new investment in healthcare logistics as demand for the temperature-controlled category booms, CNBC has learned exclusively. The $48 million investment will go toward improving 27 temperature-controlled facilities across its domestic and international businesses.
Alibaba's aggressive investments in quick commerce/fulfillment capabilities have driven accelerated double digits revenue growth against the mature e-commerce segment, albeit pressuring EBITA margins. The same has been observed in the AI/cloud capabilities and the higher capex trends triggering the negative Free Cash Flow generation, albeit mitigated by the rich balance sheet. These headwinds have contributed to BABA's overly done meltdown and discounted P/E of 15.92x, with the stock now offering a more than doubling upside potential to my LTPT of $277.80.
NEOS S&P 500 High Income ETF (SPYI) has surpassed $10B AUM, driven by strong inflows and investor demand for high-yield income solutions. SPYI's two-leg options strategy enables robust monthly distributions (11.86% yield) while retaining partial upside, outperforming peers JEPI and XYLD since inception. The ETF's tax-efficient structure, blending Section 1256 contracts and return of capital, enhances after-tax income for taxable investors.
Microsoft is still rated as a Strong Buy as valuation nears five-year lows and the long-term uptrend remains intact, demonstrating tremendous resilience. MSFT faces heightened AI-driven competitive threats, but its integrated software stack and robust free cash flow margins provide robust defense. AI monetization is nascent, and Copilot seat adoption and more cost-efficient models could drive future upside, especially as token-maxxing pressures mount.
Stocks are having a quiet morning Monday as investors come off a long holiday weekend with a close eye on peace talks between the U.S. and Iran; a second day of negotiations in Switzerland has reportedly concluded after renewed threats against Iran from President Trump and continued attacks in Lebanon by Israel made for an eventful first day of talks; earnings from FedEx and Micron are on tap this week, along with the release of the Fed's preferred measure of inflation; SpaceX shares are poised to start this week with a third straight day of declines; and shares of Apogee Therapeutics are soaring on news it is being acquired by AbbVie for $11 billion. Here's what you need to know today.